Clinical Trial Update: Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating MTBVAC in newborns in Sub-Saharan Africa to assess efficacy, safety, and immunogenicity for tuberculosis. The study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• MTBVAC

Snippet

Sponsor: Biofabri, S.L | Conditions: Tuberculosis | Phase 3 | Status: RECRUITING